Pesquisas alternativas:
daily comparing » family comparing (Expandir a Pesquisa), daily comparisons (Expandir a Pesquisa), rapidly comparing (Expandir a Pesquisa)
cancer non » cancer new (Expandir a Pesquisa), cancer na (Expandir a Pesquisa), cancer novel (Expandir a Pesquisa)
nail comor » nail tumor (Expandir a Pesquisa)
comps con » compost con (Expandir a Pesquisa), comps los (Expandir a Pesquisa)
comor dan » comer dan (Expandir a Pesquisa), como dano (Expandir a Pesquisa), bogor dan (Expandir a Pesquisa)
con netw » con net (Expandir a Pesquisa), con nee (Expandir a Pesquisa), soc netw (Expandir a Pesquisa)
l comps » m comps (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
daily comparing » family comparing (Expandir a Pesquisa), daily comparisons (Expandir a Pesquisa), rapidly comparing (Expandir a Pesquisa)
cancer non » cancer new (Expandir a Pesquisa), cancer na (Expandir a Pesquisa), cancer novel (Expandir a Pesquisa)
nail comor » nail tumor (Expandir a Pesquisa)
comps con » compost con (Expandir a Pesquisa), comps los (Expandir a Pesquisa)
comor dan » comer dan (Expandir a Pesquisa), como dano (Expandir a Pesquisa), bogor dan (Expandir a Pesquisa)
con netw » con net (Expandir a Pesquisa), con nee (Expandir a Pesquisa), soc netw (Expandir a Pesquisa)
l comps » m comps (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
1
“... biomarkers in breast cancer patients. Three biomarkers, S100A8 (p-value = 0.0069, 7.8-fold increase), S100A9...”
Obter o texto integral
Obter o texto integral
Artigo
2
“... biomarkers in breast cancer patients. Three biomarkers, S100A8 (p-value = 0.0069, 7.8-fold increase), S100A9...”
Obter o texto integral
Obter o texto integral
Artigo
3
Por Daily, Laura R., Boone, Jonathan D., Machemehl, Hannah C., Thomas, Eric D., McGwin, Gerald, Straughn, J. Michael, Leath, Charles A.
Publicado no Int J Gynecol Cancer (2017)
“...OBJECTIVES: The objectives of this study were to compare preoperative and postoperative tumor grade...”Publicado no Int J Gynecol Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation
Por Gedaly, Roberto, Galuppo, Roberto, Musgrave, Yolanda, Angulo, Paul, Hundley, Jonathan, Shah, Malay, Daily, Michael F., Chen, Changguo, Cohen, Donald A., Spear, Brett T., Evers, B. Mark
Publicado no J Surg Res (2013)
“... kinase inhibition of non liver cancer stem cell lines (PLC and HuH7) and liver cancer stem cell (LCSC...”Publicado no J Surg Res (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Shah, Monjri M., Erickson, Britt K., Matin, Tasnia, McGwin, Gerald, Martin, Jovana Y., Daily, Laura Becca, Pasko, Daniel, Haygood, Christen W., Fauci, Janelle M., Leath, Charles A.
Publicado no Gynecol Oncol (2014)
“...OBJECTIVE: Diabetes mellitus (DM) is a risk factor for endometrial cancer and is associated...”Publicado no Gynecol Oncol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Segawa, Y, Ueoka, H, Kiura, K, Kamei, H, Tabata, M, Sakae, K, Hiraki, Y, Kawahara, S, Eguchi, K, Hiraki, S, Harada for the Okayama Lung Cancer Study Group, Mine
Publicado em 2000
“... is associated with a survival advantage for selected patients with locally advanced unresectable non-small-cell...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“...-1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory mediators...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011
“... no overall survival (OS) benefit for PCI in stage III non–small-cell lung cancer (NSCLC) at 1 year. However...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por HERNÁNDEZ-VALERO, MARÍA A., THOMSON, CYNTHIA A., HERNÁNDEZ, MIKE, TRAN, TAYLOR, DETRY, MICHELLE A., THERIAULT, RICHARD L., HAJEK, RICHARD A., PIERCE, JOHN P., FLATT, SHIRLEY W., CAAN, BETTE J., JONES, LOVELL A.
Publicado em 2008
“... cancer survivors in the Women's Healthy Eating and Living study, a randomized plant-based dietary...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Publicado no Oncologist (2015)
Assuntos:
“...Lung Cancer...”Publicado no Oncologist (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...Radiotherapy has been the mainstay of the treatment of stage III non-small cell lung cancer (NSCLC...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
13
Por Zell, Jason A., Ziogas, Argyrios, Bernstein, Leslie, Clarke, Christina A., Deapen, Dennis, Largent, Joan A., Neuhausen, Susan L., Stram, Daniel O., Ursin, Giske, Anton-Culver, Hoda
Publicado em 2010
“...A low meat diet and regular non-steroidal anti-inflammatory drugs (NSAIDs) have been associated...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Novello, S, Mazières, J, Oh, I -J, de Castro, J, Migliorino, M R, Helland, Å, Dziadziuszko, R, Griesinger, F, Kotb, A, Zeaiter, A, Cardona, A, Balas, B, Johannsdottir, H K, Das-Gupta, A, Wolf, J
Publicado no Ann Oncol (2018)
“...: ALUR (MO29750; NCT02604342) was a randomized, multicenter, open-label, phase III trial of alectinib...”Publicado no Ann Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Shiffman, Saul, Dunbar, Michael S., Benowitz, Neal L.
Publicado no Cancer Epidemiol Biomarkers Prev (2014)
“...BACKGROUND: Non-daily or intermittent smokers (ITS) are increasingly common, but how much nicotine...”Publicado no Cancer Epidemiol Biomarkers Prev (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Hirsch, Fred R., Kabbinavar, Fairooz, Eisen, Tim, Martins, Renato, Schnell, Fredrick M., Dziadziuszko, Rafal, Richardson, Katherine, Richardson, Frank, Wacker, Bret, Sternberg, David W., Rusk, Jason, Franklin, Wilbur A., Varella-Garcia, Marileila, Bunn, Paul A., Camidge, D. Ross
Publicado em 2011
“...PURPOSE: Erlotinib prolongs survival in patients with advanced non–small-cell lung cancer (NSCLC...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Lin, Jianqing, Zahurak, Marianna, Beer, Tomasz M., Ryan, Charles. J., Wilding, George, Mathew, Paul, Morris, Michael, Callahan, Jennifer. A., Gordon, Gilad, Reich, Steven D., Carducci, Michael A., Antonarakis, Emmanuel S.
Publicado em 2011
“... was defined as a ≥50% increase (and >5 ng/mL) in PSA from baseline or post-treatment nadir. Endpoints included...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Almenar Cubells, D, Bosch Roig, C, Jiménez Orozco, E, Álvarez, R, Cuervo, JM, Díaz Fernández, N, Sánchez Heras, AB, Galán Brotons, A, Giner Marco, V, Codes M De Villena, M
Publicado em 2013
“... that pegfilgrastim, compared with a daily G-CSF, and PP, compared with SP, could be more effective in preventing...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... interval (95% CI): 0.62,0.95) and 0.76 (95% CI: 0.65,0.88), respectively, compared to nonusers. Daily doses...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... was obtained from a prospective prostate cancer database. RESULTS: Radical prostatectomy was completed without...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo